Skip to main content
Fig. 3 | BMC Nephrology

Fig. 3

From: Significance of urinary fatty acid-binding protein 4 level as a possible biomarker for the identification of minimal change disease in patents with nephrotic-range proteinuria

Fig. 3

Yearly declines in eGFR in low and high groups of urinary FABPs. a, b. Yearly changes (post - pre) in estimated glomerular filtration rate (eGFR) in patients (n = 33) divided by median values of urinary fatty acid-binding protein 4 (U-FABP4) (0.72 μg/gCr) (a) and urinary fatty acid-binding protein 1 (U-FABP1) (6.77 μg/gCr) (b). *P < 0.05

Back to article page